Insight Molecular Diagnostics (IMDX) Cash & Equivalents (2015 - 2026)
Insight Molecular Diagnostics (IMDX) recorded Cash & Equivalents of $17.8 million in Q2 2026, down 26.7% from $24.3 million a year earlier and down 36.9% from the prior quarter.
Powered by 
Analysis
Insight Molecular Diagnostics (IMDX) Cash & Equivalents (2015 - 2026) Analysis & Trends
At the end of FY2025, Insight Molecular Diagnostics reported Cash & Equivalents of $11.58 million, up 34.1% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 10.2% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $8.64 million in FY2024 (-8.4%), $9.43 million in FY2023 (-52.8%), $19.99 million in FY2022 (-39.3%) and $32.95 million in FY2021 (+361.3%).
- Quarterly Cash & Equivalents has ranged from $3.4 million in Q3 2024 to $44.84 million in Q2 2022 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 122.5%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 454.1% in Q1 2025, against a decline of 75.4% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $28.2 million (Q1 2026), $11.58 million (Q4 2025) and $18.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Insight Molecular Diagnostics | 112.22 Mn | 35.94 Mn | 157,000.00 | 17.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.80 Mn |
| Mar 31, 2026 | 28.20 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 24.30 Mn |
| Mar 31, 2025 | 31.03 Mn |
| Dec 31, 2024 | 8.64 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 9.30 Mn |
| Mar 31, 2024 | 5.60 Mn |
| Dec 31, 2023 | 9.43 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 17.40 Mn |
| Mar 31, 2023 | 11.80 Mn |
| Dec 31, 2022 | 19.99 Mn |
| Sep 30, 2022 | 32.10 Mn |
| Jun 30, 2022 | 44.84 Mn |
| Mar 31, 2022 | 20.41 Mn |
| Dec 31, 2021 | 32.95 Mn |
| Sep 30, 2021 | 43.34 Mn |
API Access
Insight Molecular Diagnostics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();